Public annual accounts

DeeCide financials

A multi-period view of the public annual-account figures reported for DeeCide, with comparable measures and links to available source documents.

Company overview
Registry number

0674965689

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

2025 versus 2024

Operating line
€968,689

-1.5%

EBITDA
€521,673

-13.8%

Total assets
€1,607,841

+17.6%

Equity
€1,451,622

+20.2%

EBITDA margin +53.9% · Equity ratio +90.3%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO
Fiscal year
Gross margin
EBITDA
Total assets
Equity
Filing
202531 Dec 2025€968,689€521,673€1,607,841€1,451,622-
202431 Dec 2024€983,426€605,450€1,367,215€1,207,470-
Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report